24 May 2023 | News
Jurong facility investment comes at a critical time as the advancement of biologics is reshaping the way many diseases are prevented, diagnosed, and treated
West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administration, has inaugurated its newly advanced manufacturing facility in Jurong, Singapore. This is part of West’s commitment to invest more than $350 million globally in 2023, with the majority used to expand capacity and deliver on demand of drug customers for the West’s products and services, and to meet the growing needs of customers to support sensitive and complex molecules and the changing regulatory environment.
This facility investment enables West to serve its customers’ requirements by providing high-quality containment products for injectable drugs at one location, from start to finish, in the Asia Pacific region, helping to reduce overall lead times for customers.
With West's robust capital expansion programme, the 18,000-square-meter Jurong facility is now equipped with industry-leading coating, pharmaceutical washing, sterilisation and automated vision inspection capabilities for elastomers.
Jurong facility now has the capabilities to manufacture a full range of advanced containment products, such as components having Westar Select quality level, Envision verification process, and FluroTec barrier film, to meet the healthcare industry’s growing focus on biologics, including cell and gene therapeutics.
West employs more than 600 people across three locations in Singapore - the JTC Summit Office, the Jurong plant, and the Gemini laboratory. To date, over 200 new jobs have been created as part of the investment and approximately 40 additional roles are expected to be added by the end of 2023.
From Left to Right: Bernard Birkett, Senior Vice President, Chief Financial and Operations Officer; Marcus Tang, Senior Director, Operations, Jurong; Eric Green, President, CEO and Chair of the Board of Directors; Goh Wan Yee, SVP and Head of Healthcare, EDB; and Alagu Subramaniam, Senior Director, Sales and Commercial Operations, Asia Pacific at the inauguration ceremony of West's upgraded manufacturing facility in Singapore